News

Super Micro Computer stock fell 4.4% Wednesday after it delayed the filing of its quarterly 10-Q form to the Securities and Exchanges Commission. It also has yet to file its 10-K annual report for ...
Nasdaq Listed Alerts Market: Closed QVC Group, Inc. Series A Common Stock (QVCGA) Volume: 35,033 52 Week Range: 2.26 - 39.74 ...
Dune Acquisition Corporation II Rings the Closing Bell 0 of 16 minutes, 59 secondsVolume 0% ... June 26, 2025 — 3:45 PM - 4:15 PM ET Nasdaq MarketSite, 4 Times Square, New York About This Event ...
Qlib’s leap from niche to mainstream: Once a toolkit for finance geeks, Qlib is now surging up GitHub’s trending charts. AI Agents are the new quant superpower: The latest R&D Agent update ...
QVC Group is streaming 24/7 on TikTok featuring original QVC and HSN content specific to the platform. Last year, QVC also launched products on TikTok Shop, the social media platform’s e ...
ProPhase Labs received a 180-day extension from Nasdaq to meet its $1.00 bid price compliance requirement. Quiver AI Summary ProPhase Labs Inc. announced that it has received a 180-day extension ...
Nvidia (NASDAQ: NVDA) is probably the hottest artificial intelligence (AI) stock on the planet, with its revenue and share price soaring to records in recent quarters. As a result, you may expect ...
Altimmune's Phase 2b trial of pemvidutide showed significant MASH resolution, liver fat reduction, and favorable safety outcomes.
CANTON − The Hall of Fame Resort & Entertainment Co. expects its common stock to be delisted by the Nasdaq Capital Market on June 27. The company, which was created to develop the Hall of Fame ...
QVC Group is streaming 24/7 on TikTok featuring original QVC and HSN content specific to the platform. Last year, QVC also launched products on TikTok Shop, the social media platform’s e ...
Minovia Therapeutics, an Israeli biotech hoping to get to the root causes of disease and aging, is planting itself onto the Nasdaq through a special purpose acquisition company transaction valued at ...
The delisting has not impacted clinical timelines or research staffing. Clinical Pipeline Update: The Company’s lead candidates—LP-310 for oral lichen planus and LP-10 for hemorrhagic ...